ANKRD27 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.40519834551856E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.09379999946313E-07 |
Normal-vs-Stage2 |
2.41269999999849E-05 |
Normal-vs-Stage3 |
6.78035405599076E-12 |
Normal-vs-Stage4 |
1.44180001271366E-09 |
Stage1-vs-Stage2 |
4.192600E-01 |
Stage1-vs-Stage3 |
1.675640E-03 |
Stage1-vs-Stage4 |
1.549820E-02 |
Stage2-vs-Stage3 |
1.685830E-01 |
Stage2-vs-Stage4 |
2.907000E-01 |
Stage3-vs-Stage4 |
7.617800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.00900415695082E-11 |
Normal-vs-AfricanAmerican |
3.48689999996044E-06 |
Normal-vs-Asian |
8.848000E-01 |
Caucasian-vs-AfricanAmerican |
7.507600E-01 |
Caucasian-vs-Asian |
4.844300E-02 |
AfricanAmerican-vs-Asian |
6.179900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.1414428270391E-13 |
Normal-vs-Female |
3.86490000003903E-06 |
Male-vs-Female |
1.139240E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.53130000013491E-07 |
Normal-vs-Age(41-60Yrs) |
1.23440002663955E-09 |
Normal-vs-Age(61-80Yrs) |
7.87800047419296E-10 |
Normal-vs-Age(81-100Yrs) |
3.363100E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.636400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.727570E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.107000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.429600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.413600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.576600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.260800E-01 |
Normal-vs-Grade 2 |
7.51690000244665E-08 |
Normal-vs-Grade 3 |
6.48014975013211E-12 |
Normal-vs-Grade 4 |
9.40090005840943E-10 |
Grade 1-vs-Grade 2 |
3.756200E-03 |
Grade 1-vs-Grade 3 |
2.796600E-04 |
Grade 1-vs-Grade 4 |
3.978200E-04 |
Grade 2-vs-Grade 3 |
1.702180E-02 |
Grade 2-vs-Grade 4 |
2.879500E-03 |
Grade 3-vs-Grade 4 |
1.997590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.202500E-03 |
Normal-vs-ccB subtype |
1.62714286489063E-12 |
ccA subtype-vs-ccB subtype |
4.68010075138636E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.95499966110435E-10 |
Normal-vs-N1 |
4.49970000000466E-05 |
N0-vs-N1 |
4.194200E-01 |
|
|